Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

337.92 -4.48 (-1.31%)

Streaming Delayed Price Updated: 1:40 PM EST, Nov 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

61 62 Next >

10 Health Care Stocks Whale Activity In Today's Session ↗

January 04, 2024

Via Benzinga

Will the Biotech sector sustain its momentum in 2024?

January 04, 2024

The iShares Biotechnology ETF (NASDAQ: IBB) emerged as a standout star, closing the first day of the year with a solid upswing of nearly 4%.

Via MarketBeat

Topics ETFs

Revenge of the Boring Stocks! Dividends Are Sexy Again. ↗

January 03, 2024

Dividend stocks are leading the way in the first few days of 2024, indicating that boring is back! What that means for investors now.

Via InvestorPlace

Did Santa Claus Claus Leave Town A Day Early? ↗

January 02, 2024

With the exception of the Dow, stocks are down hard to begin the new calendar year.

Via Talk Markets

Topics Stocks

Amgen Inc. (NASDAQ: AMGN) Records 52-Week High Tuesday Morning

January 02, 2024

Via Investor Brand Network

Amgen's Options: A Look at What the Big Money is Thinking ↗

December 28, 2023

Via Benzinga

Analyzing Amgen In Comparison To Competitors In Biotechnology Industry ↗

December 25, 2023

Via Benzinga

Is NASDAQ:AMGN a Good Fit for Dividend Investing? ↗

December 22, 2023

Why AMGEN INC (NASDAQ:AMGN) is a Top Pick for Dividend Investors.

Via Chartmill

Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024 ↗

January 02, 2024

Twenty eight of the 30 Dow Jones Industrial Average components pay out dividends. A look at the top ten highest dividend yields.

Via Benzinga

Topics Stocks

3 Top ETFs I'm Planning to Buy Hand Over Fist in 2024, Despite All the Cheap Stocks on My Radar ↗

January 01, 2024

I'm adding some ETFs to my retirement portfolio in 2024; here are the three I'm starting with.

Via The Motley Fool

Topics ETFs Retirement

Amgen Stock Sees Relative Strength Rating Improve To 74 ↗

December 29, 2023

Amgen stock saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 74.

Via Investor's Business Daily

There Are Only 5 Dow Stocks I Wouldn't Buy in 2024 ↗

December 29, 2023

There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.

Via The Motley Fool

Topics Stocks

Spotlight on Amgen: Analyzing the Surge in Options Activity ↗

December 21, 2023

Via Benzinga

Looking Into Amgen's Recent Short Interest ↗

December 20, 2023

Via Benzinga

In-Depth Examination Of 18 Analyst Recommendations For Amgen ↗

December 19, 2023

Via Benzinga

Full Approval For Amgen's Flagship Cancer Drug Lumakras Pushed For Around Four Years ↗

December 26, 2023

Amgen Inc (NASDAQ: AMGN) announced that the FDA has reviewed the company's supplemental New Drug Application, seeking full approval of the KRAS-blocking drug

Via Benzinga

3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’ ↗

December 21, 2023

It's now time to take a look at these three biotech stocks to buy, as each one is currently within TradeSmith's "Green Zone."

Via InvestorPlace

CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief ↗

December 20, 2023

The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy.

Via InvestorPlace

Amgen Provides Exposure To Obesity Drug At A Reasonable Price, Says Bullish Analyst ↗

December 19, 2023

Amgen, Inc. (NASDAQ: AMGN) shares have been in focus amid developments in the AI-powered healthcare space.

Via Benzinga

Uber To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 19, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Is Amgen Stock a Buy Now? ↗

December 17, 2023

Boring businesses can be successful, too.

Via The Motley Fool

Market Whales and Their Recent Bets on AMGN Options ↗

December 14, 2023

Via Benzinga

Insights Into Amgen's Performance Versus Peers In Biotechnology Sector ↗

December 11, 2023

Via Benzinga

Healthcare Sector Stocks: Consistent Above-Average Growth And Income ↗

December 18, 2023

The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.

Via Talk Markets

1 Biotech Stock That Could Be the Next Amgen ↗

December 13, 2023

The emergence of genomic medicine as a viable modality could transform this midcap biotech into the next Amgen.

Via The Motley Fool

Better Growth Stock: Viking Therapeutics or Iovance Biotherapeutics? ↗

December 12, 2023

Both of these pharma stocks could be big winners. But one stock screens as a better buy from a risk standpoint.

Via The Motley Fool

PVH To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

December 12, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

P/E Ratio Insights for Amgen ↗

December 06, 2023

Via Benzinga

Looking Into Amgen's Recent Short Interest ↗

November 30, 2023

Via Benzinga

Analyst Ratings for Amgen ↗

November 29, 2023

Via Benzinga

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

61 62 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.